101012-32-2

Basic information

• Product Name: (2-Chloropyridin-3-yl)acetonitrile
• Synonyms: (2-Chloropyridin-3-yl)acetonitrile;2-Chloro-3-pyridineaceton...;(2-Chloropyridin-3-yl)acetonitrile 95+%;2-Chloro-3-(cyanomethyl)pyridine;2-(2-Chloropyridin-3-yl)acetonitrile;2-Chloro-3-pyridineacetonitrile;2-Chloropyridine-3-acetonitrile;3-Pyridineacetonitrile, 2-chloro-
• CAS NO: 101012-32-2
• Molecular Formula: C₇H₅ClN₂
• Molecular Weight: 152.58
• Mol File: 101012-32-2.mol
• Article Data: 14

Chemical Properties

• Melting Point: 85-86 °C(Solv: ethyl ether (60-29-7); ligroine (8032-32-4))
• Boiling Point: 294.1 °C at 760 mmHg
• Flash Point: 131.7 °C
• Appearance: /
• Density: 1.262 g/cm³
• Vapor Pressure: 0.00166mmHg at 25°C
• Refractive Index: 1.553
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -0.43±0.10(Predicted)
• CAS DataBase Reference: (2-Chloropyridin-3-yl)acetonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: (2-Chloropyridin-3-yl)acetonitrile(101012-32-2)
• EPA Substance Registry System: (2-Chloropyridin-3-yl)acetonitrile(101012-32-2)

Safety Data

• Hazardous Substances Data: 101012-32-2(Hazardous Substances Data)

Usage

Uses

2-(2-Chloropyridin-3-yl)acetonitrile is a useful reagent in the preparation of spirocyclic oxindole analog(spiro[piperidine-?4,?3''-?pyrrolo[2,?3-?b]?pyridin]?-?2''(1''H)?-?one) with anti-tumor properties.

InChI:InChI=1/C7H5ClN2/c8-7-6(3-4-9)2-1-5-10-7/h1-2,5H,3H2

Upstream product

• 6635-88-7 3-(cyanomethyl)pyridine 1-oxide 
• 89581-84-0 2-chloro-3-(chloromethyl)pyridine 
• 143-33-9 sodium cyanide 
• 40134-18-7 methyl 2-chloropyridine-3-carboxylate 
• 773837-37-9 sodium cyanide 
• 166770-75-8 (2-chloropyridin-3-yl)methyl methanesulfonate 
• 42330-59-6 (2-chloropyrid-3-yl)methanol 
• 2942-59-8 2-chloronicotinic acid 
• 49609-84-9 2-Chloronicotinoyl chloride 
• 59-67-6 nicotinic acid 
• 151-50-8 potassium cyanide 
• 10025-87-3 trichlorophosphate 

Downstream Products

• 127555-70-8 1-(4-Chlorophenyl)-1,3-dihydro-2H-pyrrolo[2,3-b]-pyridin-2-one 
• 127555-16-2 1-(4-Methoxy-phenyl)-1,3-dihydro-pyrrolo[2,3-b]pyridin-2-one 
• 127555-84-4 1-(3,5-Dichloro-phenyl)-1,3-dihydro-pyrrolo[2,3-b]pyridin-2-one 
• 127555-83-3 1-(2,4-Difluoro-phenyl)-1,3-dihydro-pyrrolo[2,3-b]pyridin-2-one 
• 884049-52-9 spiro[piperidine-4,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one 
• 885031-86-7 tert-butyl 2'-oxo-1',2'-dihydro-1H-spiro[piperidine-4,3'-pyrrolo[2.3-b]pyridine]-1-carboxylate 
• 845552-76-3 1-benzyl-1',2'-dihydrospiro[piperidine-4,3'-pyrrolo[2,3-b]-pyridine] 
• 845552-77-4 1-benzyl-4-(2-chloropyridin-3-yl)piperidine-4-carbonitrile 
• 100960-03-0 (2-hydroxy-[3]pyridyl)-acetic acid 
• 101860-97-3 2-amino-3-pyridylacetic acid 
• 61494-55-1 2-Chloro-pyridin-3-yl acetic acid 
• 1021303-49-0 C₁₈H₂₂ClN₃ 
• 845552-79-6 1-benzyl-1'-methyl-1',2'-dihydrospiro[piperidine-4,3'-pyrrol[2,3-b]pyridine] 
• 1202067-02-4 meso-N-(2-fluoro-4-iodophenyl)-3-[(3aR*,6aS*)-tetrahydro-5H-spiro[1,3-dioxolo[4,5-c]pyrrole-2,4'-piperidin]-5-ylcarbonyl]thieno[2,3-b]pyridin-2-amine 

Relevant articles and documents

Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists

We designed and synthesized novel N-substituted 7-azaindoline derivatives as selective M1 and M4 muscarinic acetylcholine receptors (mAChRs) agonists. Hybridization of compound 2 with the HTS hit compound 5 followed by optimization of the N-substituents of 7-azaindoline led to identification of compound 1, which showed highly selective M1 and M4 mAChRs agonistic activity, weak human ether-a-go-go related gene inhibition, and good bioavailability in multiple animal species.

TOPICAL FORMULATIONS

Provided herein are gelled topical formulations for the treatment of skin diseases comprising: a) a MEK inhibitor; b) one or more organic solvents in an amount of about 70% to about 99% by weight; and c) a gelling agent; wherein the one or more organic solvents are selected from the group consisting of C2-6 alcohol, a C2-6 alkylene glycol, a di-(C2-6 alkylene) glycol, a polyethylene glycol, C1-3 alkyl-(OCH2CH2)1-5-OH, DMSO, ethyl acetate, acetone, N-methyl pyrrolidone, benzyl alcohol, glycerin, and an oil; the gelling agent is hydroxypropyl cellulose having a molecular weight ranging from about 40,000 Dato about 2,500,000 Da; and wherein the gelled topical formulation has a viscosity of from 1 to 25,000 cps; and DMSO, when present, is combined with at least one other of said organic solvents such that DMSO is present in an amount of less than 50% by weight.

ARYL-ANILINE AND HETEROARYL-ANILINE COMPOUNDS FOR TREATMENT OF BIRTHMARKS

Provided herein are compounds and pharmaceutical compositions thereof for treating a birthmark in a subject in need thereof, wherein the compound is according to any one of formula (1), (II), (III), (IV), and (V). wherein X1, X2, X3, R1, R2, R2a, R13, R13a, R23, R23a, R23b, R33, R33a, R33b, R43, R43a, R51, R53, R53a, R53b, bond "a", and subscript n are described herein.